iRhythm executive nets shares from RSU vesting

iRhythm Holdings, Inc. reported insider equity activity by Chief Medical/Scientific Officer and EVP Advanced Technology Minang Turakhia.

Rhea-AI Filing Summary

iRhythm Holdings, Inc. reported insider equity activity by Chief Medical/Scientific Officer and EVP Advanced Technology Minang Turakhia. On August 7, 2026, he acquired 13,589 shares of common stock at $0.00 per share upon the Compensation & Human Capital Management Committee determining that performance conditions were met for previously granted performance RSUs from August 7, 2023. On August 10, 2026, he sold 7,093 shares of common stock at an average price of $124.6512 per share; these shares were sold to cover tax withholding and remittance obligations related to the vesting of the performance RSUs.

Insider Trade Summary

Net Seller: 7,093 shares

Net Sell 2 txns

Insider Turakhia Minang

Role CHIEF MED/SCI OFCR EVP ADVTECH

Sold 7,093 shs ($884K)

Type	Security	Shares	Price	Value
Sale	Common Stock F2	7,093	$124.6512	$884K
Grant/Award	Common Stock F1	13,589	$0.00	$0.00

Holdings After Transaction: Common Stock — 60,116 shares (Direct)

Footnotes (2)

1. F1. Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.
2. F2. These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.

Key Figures

Shares acquired via performance RSUs: 13,589 shares Shares sold to cover taxes: 7,093 shares Sale price per share: $124.6512 per share +1 more

4 metrics

Shares acquired via performance RSUs 13,589 shares Acquisition on August 7, 2026 upon satisfaction of performance conditions for RSUs granted August 7, 2023

Shares sold to cover taxes 7,093 shares Sale on August 10, 2026 to cover tax withholding and remittance obligations from RSU vesting

Sale price per share $124.6512 per share Average price for 7,093 common shares sold on August 10, 2026

Net buy/sell shares 7,093 shares Net-sell direction across reported non-derivative transactions

Key Terms

performance Restricted Stock Units, tax withholding and remittance obligations, Compensation & Human Capital Management Committee, vesting

4 terms

performance Restricted Stock Units financial

"performance Restricted Stock Units ("RSUs") granted to the Reporting Person"

Performance restricted stock units (PRSUs) are promises to deliver company shares to employees or executives only if the business meets specific performance targets and any time-based holding rules. Think of them as a bonus that converts into stock only after set goals are reached, so investors watch PRSUs for two reasons: they can dilute existing shares if paid out, and they signal how closely management’s pay is tied to company performance.

tax withholding and remittance obligations financial

"sold to cover tax withholding and remittance obligations in connection"

Compensation & Human Capital Management Committee financial

"determination of the Compensation & Human Capital Management Committee of the Board"

vesting financial

"in connection with the vesting of performance RSUs"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did iRhythm Holdings (IRTC) disclose for Minang Turakhia?

iRhythm disclosed that Minang Turakhia received an award of 13,589 shares upon performance RSU vesting on August 7, 2026 and sold 7,093 shares on August 10, 2026 to cover related tax obligations.

How many iRhythm Holdings (IRTC) shares did Minang Turakhia sell and at what price?

Minang Turakhia sold 7,093 shares of iRhythm common stock on August 10, 2026 at an average price of $124.6512 per share, with the proceeds used to satisfy tax withholding and remittance obligations from RSU vesting.

What award did Minang Turakhia receive from iRhythm Holdings (IRTC) related to performance RSUs?

He acquired 13,589 shares of iRhythm common stock at $0.00 per share on August 7, 2026 when the board’s Compensation & Human Capital Management Committee determined that performance conditions for previously granted performance RSUs were met.

Were the iRhythm Holdings (IRTC) insider share sales made under a 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not affirmed for these transactions, and the footnotes do not describe any trading plan, so the reported sale to cover taxes is not identified as pursuant to a Rule 10b5-1 plan.

Why did Minang Turakhia sell iRhythm Holdings (IRTC) shares after his RSUs vested?

According to the footnote, the 7,093 shares sold on August 10, 2026 were disposed of to cover tax withholding and remittance obligations arising from the vesting of performance RSUs, rather than as a discretionary sale for portfolio reasons.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/11/2026 - 04:02 PM Accepted by SEC EDGAR 08/11/2026 - 04:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Turakhia Minang

(Last) (First) (Middle)

C/O IRHYTHM HOLDINGS, INC.

699 8TH ST #600

(Street)

SAN FRANCISCO CALIFORNIA 94103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
iRhythm Holdings, Inc. [ IRTC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF MED/SCI OFCR EVP ADVTECH

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/07/2026	08/07/2026	A		13,589(1)	A	$0	67,209	D
Common Stock	08/10/2026	08/10/2026	S		7,093(2)	D	$124.6512	60,116	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.

2. These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.

Remarks:

	/s/ Marc Rosenbaum, attorney-in-fact	08/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)